The Strategy of Management Patients with non-ST Elevation Acute Coronary Syndrome
https://doi.org/10.18087/cardio.2019.9.n366
Abstract
The review covers issues of epidemiology, diagnostics, management strategy, and treatment outcomes in patients with non-ST elevation acute coronary syndrome. Numerous factors affecting the choice of an invasive strategy are analyzed as well as its correspondence to existing recommendations of patient’s management. The stratification of risk of development of adverse coronary events, which is a part of the formation of a treatment strategy, is discussed.
About the Authors
Yu. A. Prilutskaya
Federal State Budgetary Institution "Clinical Hospital" Office of the President of the Russian Federation
Haed of departmebt of ressuscination and intensive therapy
45, Lоsinoostrovsraya street, Moscow,107150
L. I. Dvoretski
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Head of department of hospital therapy
8-2, Trubetskaya street, Moscow, 119992
References
1. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. Journal of the American College of Cardiology. 2004;44(7):1393–9. DOI: 10.1016/j.jacc.2004.06.068
2. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME et al. Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions. JACC: Cardiovascular Interventions. 2014;7(1):1–9. DOI: 10.1016/j.jcin.2013.06.016
3. Tarasov R.S., Ganyukov V.I., Barbarash O.L., Barbarash L.S. The role of the SYNTAX scale in evaluating the outcome of percutaneous coronary intervention in patients with myocardial infarction with ST segment elevation in a multivascular coronary lesion. Angiology and Vascular Surgery. 2016;22(1):38–45.
4. Hemradj VV, Ottervanger JP, van ’t Hof AW, Dambrink JH, Gosselink M, Kedhi E et al. Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention: H EMRADJ ET AL. Clinical Cardiology. 2016;39(11):665–9. DOI: 10.1002/clc.22580
5. Angelini P, Leachman R, Heibig J. Flow characteristics of coronary balloon catheters. Texas Heart Institute Journal. 1986;13(2):213–5. PMID: 15227363
6. Damman P, Jernberg T, Lindahl B, de Winter R, Jeppsson A, Johanson P et al. Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART. EuroIntervention. 2016;12(9):1108–16. DOI: 10.4244/EIJY15M11_05
7. Bokarev I.N. Острый коронарный синдром и его лечение. Consilium Medicum. 2006;8(5):72–81.
8. Bogomolov A.N., Kozlov K.L., Kurochkina O.N. Survival of elderly patients who underwent coronary artery stenting during the acute period of myocardial infarction: retrospective analysis. Success of gerontology. 2012;25(3):468–73.
9. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. Journal of the American College of Cardiology. 2004;44(7):1393–9. DOI: 10.1016/j.jacc.2004.06.068
10. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. The Lancet. 2013;381(9867):639–50. DOI: 10.1016/S0140-6736(13)60108-7
11. Bogomolov A.N., Kozlov K.L., Kurochkina O.N. Survival of elderly patients who underwent coronary artery stenting during the acute period of myocardial infarction: retrospective analysis. Success of gerontology. 2012;25(3):468–73.
12. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119–77. DOI: 10.1093/eurheartj/ehx393
13. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW et al. Acute Coronary Care in the Elderly, Part I: Non–ST-Segment–Elevation Acute Coronary Syndromes: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology. Circulation. 2007;115(19):2549–69. DOI: 10.1161/CIRCULATIONAHA.107.182615
14. Shpektor A.V., Vasilyeva E.Yu. Secondary prophylaxis of myocardial infarction. Methodical recommendations №26. 2013. DZM. 21p. Av at: https://mosgorzdrav.ru/ru-RU/science/default/download/192.html.
15. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW et al. Acute Coronary Care in the Elderly, Part I: Non–ST-Segment–Elevation Acute Coronary Syndromes: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology. Circulation. 2007;115(19):2549–69. DOI: 10.1161/CIRCULATIONAHA.107.182615
16. Boytsov S.A., Martsevich S.Yu., Kutishenko N.P., Drozdova L. Yu., Lukyanov M.M., Zagrebelny A.V. et al. Registers in cardiology: their principles, rules, and real-word potential. Cardiovascular therapy and prevention. 2013;12(1):4–9.
17. Prilutskaya Yu.A., Dvoretsky L.I. Optimization of Invasive Treatment Strategy in Patients With Non-ST Elevation Acute Coronary Syndrome. Kardiologiia. 2018;58(1):5–10. DOI: 10.18087/cardio.2018.1.10077
18. Menozzi Alberto, De Luca Leonardo, Olivari Zoran, Rossini Roberta, Ferlini Marco, Daniela Lina et al. I pazienti con sindrome coronarica acuta senza sopraslivellamento persistente del tratto ST non sottoposti a rivascolarizzazione coronarica: una popolazione sottotrattata. Giornale Italiano di Cardiologia. 2016;17(10):816–26. DOI: 10.1714/2464.25800
19. Menozzi Alberto, De Luca Leonardo, Olivari Zoran, Rossini Roberta, Ferlini Marco, Daniela Lina et al. I pazienti con sindrome coronarica acuta senza sopraslivellamento persistente del tratto ST non sottoposti a rivascolarizzazione coronarica: una popolazione sottotrattata. Giornale Italiano di Cardiologia. 2016;17(10):816–26. DOI: 10.1714/2464.25800
20. Yavelov I.S. Treatment of acute coronary syndrome without ST segment elevation in Russia (according to data from the registers of acute coronary syndromes in 2000—2001 and 2003). Russian Heart Journal. 2004;3(4):210–3.
21. Parshin E.A., Chudinov I.L., Kuzheleva E.A. Analytical data processing register of acute myocardial infarction. International Journal of Applied and Basic Research. 2016;2–3:408–9.
22. Mirkhazanova L.R. The effectiveness of coronary stenting and conservative therapy in elderly and senile patients: the results of a long prospective observation. Rational Pharmacotherapy in Cardiology. 2011;7(6):708–12.
23. Mirkhazanova L.R. The effectiveness of coronary stenting and conservative therapy in elderly and senile patients: the results of a long prospective observation. Rational Pharmacotherapy in Cardiology. 2011;7(6):708–12.
24. Tomescu M, Pogorevici A, Citu I, Bordejevic D, Caruntu F. Canada acute coronary syndrome score was a stronger baseline predictor than age ≥75 years of in-hospital mortality in acute coronary syndrome patients in western Romania. Clinical Interventions in Aging. 2016;26(11):481–8. DOI: 10.2147/CIA.S104943
25. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ. 1993;307(6900):349–53. DOI: 10.1136/bmj.307.6900.349
26. Oshchepkova E.V., Dmitriev V.A., Gridnev V.I., Dovgalevsky P.Ya., Karpov Yu.A. Three-year experience of the registry of patients with acute coronary syndrome in regional vascular centers and primary vascular departments. Kardiologicheskij Vestnik. 2012;7(1):5–9.
27. Tomescu M, Pogorevici A, Citu I, Bordejevic D, Caruntu F. Canada acute coronary syndrome score was a stronger baseline predictor than age ≥75 years of in-hospital mortality in acute coronary syndrome patients in western Romania. Clinical Interventions in Aging. 2016;26(11):481–8. DOI: 10.2147/CIA.S104943
28. Staroverov I.I. How to treat cardiogenic shock in myocardial infarction? Russian medical journal. 2002;10(19):896–9.
29. Erlich A.D., Gratsiansky N.A. Independent register of acute coronary syndromes RECORD. Characteristics of patients and treatment before discharge from hospital. Atherothrombosis. 2009;2:105–22.
30. Numasawa Y, Sawano M, Miyata H, Ueda I, Noma S, Suzuki M et al. Outcomes After Percutaneous Coronary Intervention of Acute Coronary Syndrome Complicated With Cardiopulmonary Arrest (from a Japanese Multicenter Registry). The American Journal of Cardiology. 2017;119(8):1173–8. DOI: 10.1016/j.amjcard.2017.01.007
31. Numasawa Y, Sawano M, Miyata H, Ueda I, Noma S, Suzuki M et al. Outcomes After Percutaneous Coronary Intervention of Acute Coronary Syndrome Complicated With Cardiopulmonary Arrest (from a Japanese Multicenter Registry). The American Journal of Cardiology. 2017;119(8):1173–8. DOI: 10.1016/j.amjcard.2017.01.007
32. Ponikowski PA, Voors AD, Anker S, Bueno H, Cleland JGF, Coats A et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2017;22(1):7–81. DOI: 10.15829/1560-4071-2017-1-7-81
33. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2010;31(20):2501–55. DOI: 10.1093/eurheartj/ehq277
34. Erlich A.D., Gratsiansky N.A. The RECORD Registry. Treatment of Patients With Acute Coronary Syndromes in Hospitals With and Without Possibilities to Perform Invasive Coronary Procedures. Kardiologiia. 2010;50(7):15–20.
35. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2010;31(20):2501–55. DOI: 10.1093/eurheartj/ehq277
36. Tereshchenko S.N., Zhirov I.S., Zateyshchikov D.A., Mareev Yu.V., Nasonova S.N., Narusov O.Yu. et al. Federal clinical guidelines for the diagnosis and treatment of chronic and acute heart failure. Ministry of Health of the Russian Federation. M. 2013. 52p. Av at: http://www.minzdravrb.ru/minzdrav/docs/hosn.pdf.
37. Popovic B, Agrinier N, Voilliot D, Elfarra M, Villemot JP, Maureira P. Ventricular Dysfunction in Patients with Acute Coronary Syndrome Undergoing Coronary Surgical Revascularization: Prognostic Impact on Long-Term Outcomes. PLOS ONE. 2016;11(12):e0168634. DOI: 10.1371/journal.pone.0168634
38. Erlikh A.D., Gratsiansky N.A. Acute Non ST-Elevation Coronary Syndrome in Real Practice of Hospitals in Russia. Comparative Data From RECORD-2 and RECORD Regisries. Kardiologiia. 2012;52(10):9–16.
39. Popovic B, Agrinier N, Voilliot D, Elfarra M, Villemot JP, Maureira P. Ventricular Dysfunction in Patients with Acute Coronary Syndrome Undergoing Coronary Surgical Revascularization: Prognostic Impact on Long-Term Outcomes. PLOS ONE. 2016;11(12):e0168634. DOI: 10.1371/journal.pone.0168634
40. Shiraishi Y, Kohsaka S, Ueda I, Inohara T, Sawano M, Numasawa Y et al. Degree of dyspnoea in patients with non-ST-elevation acute coronary syndrome: A report from Japanese multicenter registry. International Journal of Clinical Practice. 2016;70(12):978–87. DOI: 10.1111/ijcp.12905
41. Yu X-F, Li Y, Wang Q-C, Wang X-Z, Liang M, Zhao X et al. Staged versus “one-time” multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome. Journal of geriatric cardiology: JGC. 2016;13(9):760–7. DOI: 10.11909/j.issn.1671-5411.2016.09.004
42. Martsevich S.Yu., Ginzburg M.L., Kutishenko N.P., Deev A.D., Fokina A.V., Daniels E.V. Lyubertsy Study of mortality in patients with acute myocardial infarction (LIS): the analysis of anamnestic predictors of in-hospital mortality. Cardiovascular Therapy and Prevention. 2012;11(1):45–8.
43. Yu X-F, Li Y, Wang Q-C, Wang X-Z, Liang M, Zhao X et al. Staged versus “one-time” multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome. Journal of geriatric cardiology: JGC. 2016;13(9):760–7. DOI: 10.11909/j.issn.1671-5411.2016.09.004
44. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H et al. A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI). Journal of the American College of Cardiology. 2014;63(20):2088–98. DOI: 10.1016/j.jacc.2014.02.530
45. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394
46. Fox K. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE). European Heart Journal. 2003;24(15):1414–24. DOI: 10.1016/S0195-668X(03)00315-4
47. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394
48. Kryzhanovskaya S.A., Matyushin G.V., Protopopov A.V. The noreflow phenomenon: factors that determine the risk of development and features of ECG changes. Functional diagnostics. 2011;3:82.
49. Novikova E.S., Komarov A.L., Gus’kova E.V., Shakhmatova O.O., Deev A.D., Dobrovolsky A.B. et al. Is the SYNTAX scale sufficient to assess the risk of patients undergoing percutaneous coronary intervention? Atherothrombosis Journal. 2017;1:80–93. DOI: 10.21518/2307-1109-2017-1-80-93
50. Shevchenko I.I., Erlikh A.D., Islamov R.R., Budyak V.A., Provotorov V.M., Gratsiansky N.A. on Behalf of Participants of RECORD and RECORD-2 Registries. Comparison of data from registries of acute coronary syndromes RECORD and RECORD-2: management of patients and its results in noninvasive hospitals. Kardiologiia. 2013;53(8):4–10.
51. Novikova E.S., Komarov A.L., Gus’kova E.V., Shakhmatova O.O., Deev A.D., Dobrovolsky A.B. et al. Is the SYNTAX scale sufficient to assess the risk of patients undergoing percutaneous coronary intervention? Atherothrombosis Journal. 2017;1:80–93. DOI: 10.21518/2307-1109-2017-1-80-93
52. Erlikh A.D. Six-month outcomes in patients with acute coronary syndrome included in the Russian register RECORD-3. Russian Journal of Cardiology. 2017;22(11):8–14. DOI: 10.15829/1560-4071-2017-11-8-14
53. Iskhakov M.M., Tagirov D.R., Gazizov N.V., Nugaybekova L.A., Sayfutdinov R.G. “No-reflow” phenomenon: clinical aspects of reperfusion failure. Kazan medical journal. 2015;96(3):391–6.
54. Tarasov R.S., Ganyukov V.I., Barbarash O.L., Barbarash L.S. The role of the SYNTAX scale in evaluating the outcome of percutaneous coronary intervention in patients with myocardial infarction with ST segment elevation in a multivascular coronary lesion. Angiology and Vascular Surgery. 2016;22(1):38–45.
55. Tarasov R.S., Ganyukov V.I., Barbarash O.L., Barbarash L.S. The role of the SYNTAX scale in evaluating the outcome of percutaneous coronary intervention in patients with myocardial infarction with ST segment elevation in a multivascular coronary lesion. Angiology and Vascular Surgery. 2016;22(1):38–45.
56. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. The Lancet. 2013;381(9867):639–50. DOI: 10.1016/S0140-6736(13)60108-7
57. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. European Heart Journal. 2008;29(23):2909–45. DOI: 10.1093/eurheartj/ehn416
58. Fox KAA, Eagle KA, Gore JM, Steg PG, Anderson FA, for the GRACE and GRACE Investigators. The Global Registry of Acute Coronary Events, 1999 to 2009-GRACE. Heart. 2010;96(14):1095–101. DOI: 10.1136/hrt.2009.190827
59. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. The Lancet. 2013;381(9867):639–50. DOI: 10.1016/S0140-6736(13)60108-7
60. Boytsov S.A., Dovgalevsky P.Ya., Gridnev V.I., Oschepkova E.V., Dmitriev V.A. Comparative analysis of Russian and foreign data on acute coronary syndrome. Kardiologicheskij Vestnik. 2010;5(1):82–6.
61. Hemradj VV, Ottervanger JP, van ’t Hof AW, Dambrink JH, Gosselink M, Kedhi E et al. Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention: H EMRADJ ET AL. Clinical Cardiology. 2016;39(11):665–9. DOI: 10.1002/clc.22580
62. Shpektor A.V., Vasilyeva E.Yu. Secondary prophylaxis of myocardial infarction. Methodical recommendations №26. 2013. DZM. 21p. Av at: https://mosgorzdrav.ru/ru-RU/science/default/download/192.html.
63. Shpektor A.V., Vasilyeva E.Yu. Secondary prophylaxis of myocardial infarction. Methodical recommendations №26. 2013. DZM. 21p. Av at: https://mosgorzdrav.ru/ru-RU/science/default/download/192.html.
64. Erlikh A.D., Gratsiansky N.A. Registry of Acute Coronary Syndromes “RECORD-3”. Characteristics of Patients and Treatment During Initial Hospitalization. Kardiologiia. 2016;56(4):16–24.
65. Prilutskaya Yu.A., Dvoretsky L.I. Optimization of Invasive Treatment Strategy in Patients With Non-ST Elevation Acute Coronary Syndrome. Kardiologiia. 2018;58(1):5–10. DOI: 10.18087/cardio.2018.1.10077
66. Damman P, Jernberg T, Lindahl B, de Winter R, Jeppsson A, Johanson P et al. Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART. EuroIntervention. 2016;12(9):1108–16. DOI: 10.4244/EIJY15M11_05
67. Prilutskaya Yu.A., Dvoretsky L.I. Optimization of Invasive Treatment Strategy in Patients With Non-ST Elevation Acute Coronary Syndrome. Kardiologiia. 2018;58(1):5–10. DOI: 10.18087/cardio.2018.1.10077
68. Yavelov I.S. Treatment of acute coronary syndrome without ST segment elevation in Russia (according to data from the registers of acute coronary syndromes in 2000—2001 and 2003). Russian Heart Journal. 2004;3(4):210–3.
69. DOI: 10.18565/cardio.2016.4.16-24
70. Yavelov I.S. Treatment of acute coronary syndrome without ST segment elevation in Russia (according to data from the registers of acute coronary syndromes in 2000—2001 and 2003). Russian Heart Journal. 2004;3(4):210–3.
71. Hamm CW, Bassand J-P, Agewall S, Bax J, Boersma E, Bueno H et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2011;32(23):2999–3054. DOI: 10.1093/eurheartj/ehr236
72. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ. 1993;307(6900):349–53. DOI: 10.1136/bmj.307.6900.349
73. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ. 1993;307(6900):349–53. DOI: 10.1136/bmj.307.6900.349
74. Staroverov I.I. How to treat cardiogenic shock in myocardial infarction? Russian medical journal. 2002;10(19):896–9.
75. Poloński L, Gasior M, Gierlotka M, Kalarus Z, Cieśliński A, Dubiel JS et al. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiologia Polska. 2007;65(8):861–72; discussion 873-874. PMID: 17853315
76. Staroverov I.I. How to treat cardiogenic shock in myocardial infarction? Russian medical journal. 2002;10(19):896–9.
77. Srimahachota S, Kanjanavanit R, Boonyaratavej S, Boonsom W, Veerakul G, Tresukosol D et al. Demographic, management practices and in-hospital outcomes of Thai Acute Coronary Syndrome Registry (TACSR): the difference from the Western world. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet. 2007;90(Suppl 1):1–11. PMID: 18431881
78. Ponikowski PA, Voors AD, Anker S, Bueno H, Cleland JGF, Coats A et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2017;22(1):7–81. DOI: 10.15829/1560-4071-2017-1-7-81
79. Ponikowski PA, Voors AD, Anker S, Bueno H, Cleland JGF, Coats A et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2017;22(1):7–81. DOI: 10.15829/1560-4071-2017-1-7-81
80. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal. 2016;37(3):267–315. DOI: 10.1093/eurheartj/ehv320
81. Tereshchenko S.N., Zhirov I.S., Zateyshchikov D.A., Mareev Yu.V., Nasonova S.N., Narusov O.Yu. et al. Federal clinical guidelines for the diagnosis and treatment of chronic and acute heart failure. Ministry of Health of the Russian Federation. M. 2013. 52p. Av at: http://www.minzdravrb.ru/minzdrav/docs/hosn.pdf.
82. Tereshchenko S.N., Zhirov I.S., Zateyshchikov D.A., Mareev Yu.V., Nasonova S.N., Narusov O.Yu. et al. Federal clinical guidelines for the diagnosis and treatment of chronic and acute heart failure. Ministry of Health of the Russian Federation. M. 2013. 52p. Av at: http://www.minzdravrb.ru/minzdrav/docs/hosn.pdf.
83. Authors/Task Force Members, Steg PhG, James SK, Atar D, Badano LP, Lundqvist CB et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2012;33(20):2569–619. DOI: 10.1093/eurheartj/ehs215
84. Shiraishi Y, Kohsaka S, Ueda I, Inohara T, Sawano M, Numasawa Y et al. Degree of dyspnoea in patients with non-ST-elevation acute coronary syndrome: A report from Japanese multicenter registry. International Journal of Clinical Practice. 2016;70(12):978–87. DOI: 10.1111/ijcp.12905
85. Shiraishi Y, Kohsaka S, Ueda I, Inohara T, Sawano M, Numasawa Y et al. Degree of dyspnoea in patients with non-ST-elevation acute coronary syndrome: A report from Japanese multicenter registry. International Journal of Clinical Practice. 2016;70(12):978–87. DOI: 10.1111/ijcp.12905
86. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology. 2013;61(4):e78–140. DOI: 10.1016/j.jacc.2012.11.019
87. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H et al. A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI). Journal of the American College of Cardiology. 2014;63(20):2088–98. DOI: 10.1016/j.jacc.2014.02.530
88. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H et al. A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI). Journal of the American College of Cardiology. 2014;63(20):2088–98. DOI: 10.1016/j.jacc.2014.02.530
89. Kryzhanovskaya S.A., Matyushin G.V., Protopopov A.V. The noreflow phenomenon: factors that determine the risk of development and features of ECG changes. Functional diagnostics. 2011;3:82.
90. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354–94. DOI: 10.1161/CIR.0000000000000133
91. Kryzhanovskaya S.A., Matyushin G.V., Protopopov A.V. The noreflow phenomenon: factors that determine the risk of development and features of ECG changes. Functional diagnostics. 2011;3:82.
92. Iskhakov M.M., Tagirov D.R., Gazizov N.V., Nugaybekova L.A., Sayfutdinov R.G. “No-reflow” phenomenon: clinical aspects of reperfusion failure. Kazan medical journal. 2015;96(3):391–6.
93. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). Journal of the American College of Cardiology. 2009;54(23):2205–41. DOI: 10.1016/j.jacc.2009.10.015
94. Iskhakov M.M., Tagirov D.R., Gazizov N.V., Nugaybekova L.A., Sayfutdinov R.G. “No-reflow” phenomenon: clinical aspects of reperfusion failure. Kazan medical journal. 2015;96(3):391–6.
95. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. European Heart Journal. 2008;29(23):2909–45. DOI: 10.1093/eurheartj/ehn416
96. Society of Emergency Cardiology Specialists. Diagnosis and treatment of patients with acute coronary syndrome without persistent elevation of the ST segment of the electrocardiogram. Recommendations of the Society of Emergency Cardiology Specialists. Recommended by the Ministry of Health of the Russian Federation. 2015. 97p. Av at: https://medspecial.ru/upload/medialibrary/aa9/диагностика и лечение.pdf.
97. Hemradj VV, Ottervanger JP, van ’t Hof AW, Dambrink JH, Gosselink M, Kedhi E et al. Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention: H EMRADJ ET AL. Clinical Cardiology. 2016;39(11):665–9. DOI: 10.1002/clc.22580
98. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. European Heart Journal. 2008;29(23):2909–45. DOI: 10.1093/eurheartj/ehn416
99. Damman P, Jernberg T, Lindahl B, de Winter R, Jeppsson A, Johanson P et al. Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART. EuroIntervention. 2016;12(9):1108–16. DOI: 10.4244/EIJY15M11_05
100. All-Russian scientific society of cardiologists. Treatment of acute coronary syndrome without persistent ST segment elevation on an ECG. Russian recommendations. Cardiovascular therapy and prevention. 2006;5(8 Suppl 1):1–32.
101. Hemradj VV, Ottervanger JP, van ’t Hof AW, Dambrink JH, Gosselink M, Kedhi E et al. Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention: H EMRADJ ET AL. Clinical Cardiology. 2016;39(11):665–9. DOI: 10.1002/clc.22580
102. Ruda M.Ya., Golitsin S.P., Gratsiansky N.A., Komarov N.A., Panchenko E.P., Staroverov I.I. et al. Diagnosis and treatment of patients with acute myocardial infarction with ST-segment elevation ECG. Russian recomendations. Cardiovascular Therapy and Prevention. 2007;6(8 S1):415–500.
103. Damman P, Jernberg T, Lindahl B, de Winter R, Jeppsson A, Johanson P et al. Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART. EuroIntervention. 2016;12(9):1108–16. DOI: 10.4244/EIJY15M11_05
104. Diagnosis and treatment of patients with acute myocardial infarction with elevation of the ST segment of the electrocardiogram. Clinical guidelines. Developed on the instructions of the Ministry of Health of Russia, approved by the Society of Emergency Cardiology Specialists and the relevant cardiology commission Ministry of Health. 2013. 152p. Av at: https://mzdrav.rk.gov.ru/file/mzdrav_18042014_Klinicheskie_rekomendacii_Ostryj_infarkt_miokarda.pdf.
105. Reuter P-G, Rouchy C, Cattan S, Benamer H, Jullien T, Beruben A et al. Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The Sisca randomized trial. International Journal of Cardiology. 2015;182:414–8. DOI: 10.1016/j.ijcard.2014.12.089
106. Badings EA, Remkes WS, The SHK, Dambrink J-HE, Tjeerdsma G, Rasoul S et al. Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial: Intervention in Transient ST-Segment Elevation ACS. Catheterization and Cardiovascular Interventions. 2016;88(5):755–64. DOI: 10.1002/ccd.26719
107. Bonello L, Laine M, Puymirat E, Lemesle G, Thuny F, Paganelli F et al. Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes. JACC: Cardiovascular Interventions. 2016;9(22):2267–76. DOI: 10.1016/j.jcin.2016.09.017
108. Wijeysundera HC, Sidhu MS, Bennell MC, Qiu F, Ko DT, Knudtson ML et al. Predictors of Initial Revascularization Versus Medical Therapy Alone in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome Undergoing an Invasive Strategy. Circulation: Cardiovascular Interventions. 2016;9(7):70–85. DOI: 10.1161/CIRCINTERVENTIONS.115.003592
109. Zhu H, Xue H, Wang H, Chen Y, Zhou S, Tian F et al. Risk stratification and prognostic value of GRACE and TIMI risk scores for female patients with non-ST segment elevation acute coronary syndrome. Minerva Cardioangiologica. 2015;63(3):171–8. PMID: 25501977
110. Fanning JP, Nyong J, Scott IA, Aroney CN, Walters DL. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane Database of Systematic Reviews. 2016;5:CD004815. DOI: 10.1002/14651858.CD004815.pub4
111. Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK et al. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation. 2009;119(14):1873–82. DOI: 10.1161/CIRCULATIONAHA.108.828541
112. Roe MT, Chen AY, Thomas L, Wang TY, Alexander KP, Hammill BG et al. Predicting long-term mortality in older patients after non–ST-segment elevation myocardial infarction: The CRUSADE long-term mortality model and risk score. American Heart Journal. 2011;162(5):875-883.e1. DOI: 10.1016/j.ahj.2011.08.010
113. Kotecha T, Rakhit RD. Acute coronary syndromes. Clinical Medicine. 2016;16(Suppl_6):s43–8. DOI: 10.7861/clinmedicine.16-6-s43
114. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal. 2014;35(37):2541–619. DOI: 10.1093/eurheartj/ehu278
115. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME et al. Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions. JACC: Cardiovascular Interventions. 2014;7(1):1–9. DOI: 10.1016/j.jcin.2013.06.016
116. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. Journal of the American College of Cardiology. 2004;44(7):1393–9. DOI: 10.1016/j.jacc.2004.06.068
117. Bogomolov A.N., Kozlov K.L., Kurochkina O.N. Survival of elderly patients who underwent coronary artery stenting during the acute period of myocardial infarction: retrospective analysis. Success of gerontology. 2012;25(3):468–73.
118. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW et al. Acute Coronary Care in the Elderly, Part I: Non–ST-Segment–Elevation Acute Coronary Syndromes: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology. Circulation. 2007;115(19):2549–69. DOI: 10.1161/CIRCULATIONAHA.107.182615
119. Menozzi Alberto, De Luca Leonardo, Olivari Zoran, Rossini Roberta, Ferlini Marco, Daniela Lina et al. I pazienti con sindrome coronarica acuta senza sopraslivellamento persistente del tratto ST non sottoposti a rivascolarizzazione coronarica: una popolazione sottotrattata. Giornale Italiano di Cardiologia. 2016;17(10):816–26. DOI: 10.1714/2464.25800
120. Mirkhazanova L.R. The effectiveness of coronary stenting and conservative therapy in elderly and senile patients: the results of a long prospective observation. Rational Pharmacotherapy in Cardiology. 2011;7(6):708–12.
121. Tomescu M, Pogorevici A, Citu I, Bordejevic D, Caruntu F. Canada acute coronary syndrome score was a stronger baseline predictor than age ≥75 years of in-hospital mortality in acute coronary syndrome patients in western Romania. Clinical Interventions in Aging. 2016;26(11):481–8. DOI: 10.2147/CIA.S104943
122. Numasawa Y, Sawano M, Miyata H, Ueda I, Noma S, Suzuki M et al. Outcomes After Percutaneous Coronary Intervention of Acute Coronary Syndrome Complicated With Cardiopulmonary Arrest (from a Japanese Multicenter Registry). The American Journal of Cardiology. 2017;119(8):1173–8. DOI: 10.1016/j.amjcard.2017.01.007
123. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2010;31(20):2501–55. DOI: 10.1093/eurheartj/ehq277
124. Popovic B, Agrinier N, Voilliot D, Elfarra M, Villemot JP, Maureira P. Ventricular Dysfunction in Patients with Acute Coronary Syndrome Undergoing Coronary Surgical Revascularization: Prognostic Impact on Long-Term Outcomes. PLOS ONE. 2016;11(12):e0168634. DOI: 10.1371/journal.pone.0168634
125. Yu X-F, Li Y, Wang Q-C, Wang X-Z, Liang M, Zhao X et al. Staged versus “one-time” multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome. Journal of geriatric cardiology: JGC. 2016;13(9):760–7. DOI: 10.11909/j.issn.1671-5411.2016.09.004
126. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394
127. Novikova E.S., Komarov A.L., Gus’kova E.V., Shakhmatova O.O., Deev A.D., Dobrovolsky A.B. et al. Is the SYNTAX scale sufficient to assess the risk of patients undergoing percutaneous coronary intervention? Atherothrombosis Journal. 2017;1:80–93. DOI: 10.21518/2307-1109-2017-1-80-93
128. Tarasov R.S., Ganyukov V.I., Barbarash O.L., Barbarash L.S. The role of the SYNTAX scale in evaluating the outcome of percutaneous coronary intervention in patients with myocardial infarction with ST segment elevation in a multivascular coronary lesion. Angiology and Vascular Surgery. 2016;22(1):38–45.
129. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. The Lancet. 2013;381(9867):639–50. DOI: 10.1016/S0140-6736(13)60108-7
130. Shpektor A.V., Vasilyeva E.Yu. Secondary prophylaxis of myocardial infarction. Methodical recommendations №26. 2013. DZM. 21p. Av at: https://mosgorzdrav.ru/ru-RU/science/default/download/192.html.
131. Prilutskaya Yu.A., Dvoretsky L.I. Optimization of Invasive Treatment Strategy in Patients With Non-ST Elevation Acute Coronary Syndrome. Kardiologiia. 2018;58(1):5–10. DOI: 10.18087/cardio.2018.1.10077
132. Yavelov I.S. Treatment of acute coronary syndrome without ST segment elevation in Russia (according to data from the registers of acute coronary syndromes in 2000—2001 and 2003). Russian Heart Journal. 2004;3(4):210–3.
133. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ. 1993;307(6900):349–53. DOI: 10.1136/bmj.307.6900.349
134. Staroverov I.I. How to treat cardiogenic shock in myocardial infarction? Russian medical journal. 2002;10(19):896–9.
135. Ponikowski PA, Voors AD, Anker S, Bueno H, Cleland JGF, Coats A et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2017;22(1):7–81. DOI: 10.15829/1560-4071-2017-1-7-81
136. Tereshchenko S.N., Zhirov I.S., Zateyshchikov D.A., Mareev Yu.V., Nasonova S.N., Narusov O.Yu. et al. Federal clinical guidelines for the diagnosis and treatment of chronic and acute heart failure. Ministry of Health of the Russian Federation. M. 2013. 52p. Av at: http://www.minzdravrb.ru/minzdrav/docs/hosn.pdf.
137. Shiraishi Y, Kohsaka S, Ueda I, Inohara T, Sawano M, Numasawa Y et al. Degree of dyspnoea in patients with non-ST-elevation acute coronary syndrome: A report from Japanese multicenter registry. International Journal of Clinical Practice. 2016;70(12):978–87. DOI: 10.1111/ijcp.12905
138. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H et al. A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI). Journal of the American College of Cardiology. 2014;63(20):2088–98. DOI: 10.1016/j.jacc.2014.02.530
139. Kryzhanovskaya S.A., Matyushin G.V., Protopopov A.V. The noreflow phenomenon: factors that determine the risk of development and features of ECG changes. Functional diagnostics. 2011;3:82.
140. Iskhakov M.M., Tagirov D.R., Gazizov N.V., Nugaybekova L.A., Sayfutdinov R.G. “No-reflow” phenomenon: clinical aspects of reperfusion failure. Kazan medical journal. 2015;96(3):391–6.
141. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. European Heart Journal. 2008;29(23):2909–45. DOI: 10.1093/eurheartj/ehn416
142. Hemradj VV, Ottervanger JP, van ’t Hof AW, Dambrink JH, Gosselink M, Kedhi E et al. Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention: H EMRADJ ET AL. Clinical Cardiology. 2016;39(11):665–9. DOI: 10.1002/clc.22580
143. Damman P, Jernberg T, Lindahl B, de Winter R, Jeppsson A, Johanson P et al. Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART. EuroIntervention. 2016;12(9):1108–16. DOI: 10.4244/EIJY15M11_05
Review
For citations:
Prilutskaya Yu.A., Dvoretski L.I. The Strategy of Management Patients with non-ST Elevation Acute Coronary Syndrome. Kardiologiia. 2019;59(9):40-51. (In Russ.) https://doi.org/10.18087/cardio.2019.9.n366
Views:
2570
Email this article 
Post a Comment 
